NEW YORK (Reuters Health) – For patients with non-ST-segment elevation acute coronary syndrome (nSTE-ACS), long-term outcomes are no different whether they undergo angiography, and revascularization if indicated, within…
NEW YORK (Reuters Health) – Data from the German drug-eluting stent (DES.DE) Registry provide no evidence of the “obesity paradox” in the setting of percutaneous coronary intervention (PCI)…
NEW YORK (Reuters Health) – Newer generation everolimus-eluting stents (EES) are significantly less likely to prompt very late stent thrombosis than are the first generation of drug-eluting stents…
NEW YORK (Reuters Health) – The everolimus-eluting stent and the sirolimus-eluting stent are equally safe and efficacious in patients with coronary artery disease, the SORT OUT IV Trial…
NEW YORK (Reuters Health) – Long-term clinical outcomes of percutaneous intervention of complex coronary bifurcation lesions are significantly better when the procedure is performed with adjunctive intravascular ultrasound…
NEW YORK (Reuters Health) – Intracoronary artery infusion of autologous stem cells after primary PCI or thrombolysis for acute myocardial infarction improves left ventricular ejection fraction and left…
NEW YORK (Reuters Health) – In patients with heart failure requiring cardiac resynchronization therapy and coexistent atrial fibrillation, AV nodal ablation (AVNA) reduces mortality and improves NYHA functional…
NEW YORK (Reuters Health) – In patients with atrial fibrillation undergoing radiofrequency catheter ablation, complication risks are higher with use of dabigatran for anticoagulation compared with uninterrupted warfarin,…
NEW YORK (Reuters Health) – Late lumen loss at 6 months is smaller with the Cre8 amphilimus-eluting stent than the Taxus paclitaxel-eluting stent in de novo percutaneous coronary…
NEW YORK (Reuters Health) – The benefits of preemptive percutaneous mitral commissurotomy (PMC) in asymptomatic patients with moderate mitral stenosis appear to outweigh the inherent risks of the…